Dr. Jaspriya Bal is an accomplished Nuclear Medicine Physician with over 14 years of experience specializing in diagnostic and therapeutic nuclear medicine. She has significant expertise in PET-CT, SPECT, and radionuclide therapies for a range of cancers. Trained across globally recognized programs, she is a Fellow of the Asian Board of Nuclear Medicine and serves as the Indian Ambassador of the Oncidium Foundation for Theranostics. Her extensive research and numerous publications underscore her leadership in precision molecular oncology.
Educational Qualification:
- MBBS – Maulana Azad Medical College, Delhi University
- DRM – Institute of Nuclear Medicine and Allied Sciences, Delhi
- Radiation Safety Officer Level II (RSO-II)
- Level 1 ICPO Certification – Radiomolecular Precision Oncology and Theranostics
- Certification – Eurolearn for Cardiac Amyloidosis Imaging, ESMIT
- Fellow – Asian Board of Nuclear Medicine (FANMB)
Professional Experience:
- Principal Consultant – Nuclear Medicine, Max Super Speciality Hospital, Saket (Present)
- Specialized expertise in PET-CT, SPECT, and radionuclide-based oncology therapies
Awards and Achievements:
- Most Trusted Nuclear Medicine Physician Award, Delhi NCR (April 2023)
- Max Gem of Excellence Award (2018)
- Winner – SNMI Conference, Jaipur (2009)
- Multiple paper and poster presentations at SNMI and international nuclear medicine conferences
- Reviewer for BJR Case Reports and Indian Journal of Urology
Professional Membership:
- Society of Nuclear Medicine (India) – Life Member
- Association of Nuclear Medicine Physicians of India (ANMPI) – Life Member
- Indian Thyroid Society (ITS)
- Oncidium Foundation – Indian Ambassador for Theranostics and RLTconnect
- Society of Nuclear Medicine and Molecular Imaging (SNMMI)
- American College of Nuclear Medicine (ACNM)
- World Association of Radiopharmaceutical and Molecular Therapy (WARMTH)
- European Association of Nuclear Medicine (EANM) – WE Group Member
- American Society of Nuclear Cardiology (ASNC)
- European Society of Medical Oncology (ESMO) – Life Member
Research Papers & Publications:
- Role of F-18 FDG in Diagnosis of Tumor Thrombus – Society of Nuclear Medicine Conference, Jaipur (2009)
- Comparative Analysis of 18F-NaF, 18F-FDG and Cocktail 18F-NaF/18F-FDG PET/CT for Evaluation of Malignancy – Society of Nuclear Medicine Conference, PGI Chandigarh (2010)
- Comparison of F-18 FDG and C-11 Methionine PET/CT for Demonstration of Subependymal Deposit in Treated Glioblastoma Multiforme – Case Report
- Comparative Evaluation of C-11 Methionine (MET-PET) and F-18 FDG PET/CT for Detection of Recurrent Brain Tumors – Society of Nuclear Medicine Conference, PGI Chandigarh (2010)
- Carcinoma Parathyroid, Hodgkin’s & Non-Hodgkin’s Lymphoma – Correlation with Imaging (Current & Ongoing Research)
- Role of F-18 FDG PET-CT in Evaluation of Bone Marrow Involvement in Lymphomas – Indian Cancer Congress (Nov 2014)
- Palliative Chemotherapy (CT) with or without Cetuximab (CTX) in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN): An Indian Retrospective Analysis – Annals of Oncology, 2018
- Utility of Gallium-68 PSMA PET/CT Scan for Staging and Treatment of Prostate Cancer in a Developing Country – Annals of Oncology, 2018
- Clinicoradiological Profile and Treatment Outcomes in Prostate Cancer at a Tertiary Care Cancer Center in India – Indian Journal of Medical and Paediatric Oncology, 2020
- Primary Hyperparathyroidism with Brown Tumors Masquerading Skeletal Metastases – Role of Functional Imaging in Diagnosis and Management – Journal of Clinical and Translational Endocrinology Case Reports, 2019
- All That Lights-Up is Not Lymphoma – Indian Journal of Hematology and Blood Transfusion, 2019
- Pleural Mesothelioma with Peritoneal Involvement Diagnosed on 18F-FDG PET/CT – Indian Journal of Respiratory Medicine, Vol. 8
- Accuracy of Ga68PSMA PET-CT in Detecting Lymph Nodal Metastases in Intermediate to High Risk Adenocarcinoma Prostate – Journal of Nuclear Medicine, June 2023
- A Rare Case of Renal Malakoplakia Incidentally Detected on 18F-FDG PET/CT in a Patient with Concomitant Breast Cancer and Lymphoma – Clinical Nuclear Medicine, 2024
- F18 FDG Imaging in a Rare Case of Solitary Primary Iliac Bone Lymphoma – Indian Journal of Haematology and Blood Transfusion, Aug 2024
- Paraneoplastic Proliferative Myositis on 18F-FDG PET/CT – Clinical Nuclear Medicine, Oct 2024
.png)
.png)